A proposal: how to tell if a cell-free assay is predictive of therapeutic potency in vivo

In our speech at Prion2014, Sonia and I discussed a few of the possible routes toward prion therapeutics. The success to date with finding small molecule inhibitors of RML prions – cpd-b, anle138b, IND24 – argues that it might be … Continue reading